Business Context and Reporting Period
Company: Iris Acquisition Corp II (Cayman Islands)
Filing Type: Form 8-K (Current Report)
Date of Report: February 18, 2026
Reporting Period: Event date February 18, 2026; Separation date February 24, 2026
The Company is an emerging growth company incorporated in the Cayman Islands. This filing announces the upcoming separation of its Units into separately tradable Class A ordinary shares and warrants.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate action regarding securities structure rather than financial performance.
| Security Class | Trading Symbol | Exchange | Details |
|---|---|---|---|
| Units | IRAB U | NYSE | 1 Class A Share + 0.5 Warrant |
| Class A Ordinary Shares | IRAB | NYSE | Par value $0.0001 |
| Warrants | IRAB WS | NYSE | Exercise price $11.50 per share |
Material Changes
- Separation of Units: Effective February 24, 2026, holders may elect to separate their Units into Class A ordinary shares and warrants for separate trading.
- Trading Symbols: Separated shares will trade under "IRAB" and warrants under "IRAB WS." Units not separated will continue trading under "IRAB U."
- Warrant Structure: No fractional warrants will be issued upon separation; only whole warrants will trade.
Guidance, Outlook, and Risks
Management Commentary: The Company announced the separation to allow holders to trade the underlying securities independently. Holders must contact their brokers to initiate the separation process with the transfer agent, Odyssey Transfer & Trust Company.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard mechanics of the separation. The warrant exercise price is subject to adjustment.
Investor Verification Checklist
- Confirm the specific deadline and procedure with your broker to separate Units before or after February 24, 2026.
- Verify the current market price of the Units (IRAB U) versus the implied value of the separated shares (IRAB) and warrants (IRAB WS).
- Review the warrant terms to understand the $11.50 exercise price and potential adjustment mechanisms.
- Check for any fractional share handling policies if the separation results in odd lots.